4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-20-001349
Chief Executive Officer acquired 900,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Anzalone Christopher Richard Chief Executive Officer | 2020-01-01 | Grant or award | +900,000 | 2,705,237 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…